In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective even in low concentrations and when combined with known antibiotics their effectiveness is improved by up to 100-fold.
Among the greatest challenges when treating life-threatening tuberculosis infections is the increasing resistance to antibiotics. But the pathogen itself also makes the life of doctors difficult: its dense mycomembrane hampers the effect of many medications. A team of scientists headed by Stephan A. Sieber, Professor of Organic Chemistry at TU Munich, has discovered a substance that perturbs the formation of this membrane significantly.
The mycomembrane of the tuberculosis pathogen Mycobacterium tuberculosis consists of a lipid double layer that encapsulates the cell wall, forming an exterior barrier. Structural hallmarks are mycolic acids, branched beta-hydroxy fatty acids with two long hydrocarbon chains. The team hypothesizes that similarly structured beta lactones could “mask” themselves as mycolic acid to enter the mycolic acid metabolic pathways and then block the decisive enzymes.
In the context of an extensive search, the interdisciplinary team of scientists hit the bullseye with the beta lactone EZ120. It does indeed inhibit the biosynthesis of the mycomembrane and kills mycobacteria effectively. Using enzyme assays and mass spectroscopy investigations, Dr. Johannes Lehmann, a researcher at the Chair of Organic Chemistry II at TU Munich, demonstrated during his doctoral work that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes.
EZ120 is effective even in low doses, easily passes the mycomembrane and exhibits only low toxicity to human cells. The combined application of this substance with known antibiotics showed a synergistic effect leading to significantly increased effectiveness.”Vancomycin, a common antibiotic, and EZ120 work together very well,” says Prof. Sieber, who heads the Chair of Organic Chemistry II. “When used together, the dose can be reduced over 100-fold.
“The scientists suspect that disrupting the mycomembrane enables antibiotics to enter the bacteria more easily. This is a new mode of action and might be a starting point for novel tuberculosis therapies.
Learn more: Double strike against tuberculosis
The Latest on: Tuberculosis
- Torres Strait: Tuberculosis fears trigger call for greater Cairns disease efforton March 2, 2021 at 7:40 pm
REPORTS of three Border Force officers contracting a devastating infectious disease have triggered calls to ramp up treatment and vaccine research in the Torres Strait.
- Development of a population pharmacokinetic model and Bayesian estimators for isoniazid in Tunisian tuberculosis patientson March 1, 2021 at 8:38 am
This study aimed to develop a population pharmacokinetic model using full pharmacokinetic (PK) profiles of isoniazid (INH) taking into account demographic and genetic covariates and to develop ...
- Tuberculosis Testing Market : Industry Outlook By Drivers, Restraintson March 1, 2021 at 12:47 am
"The report on Tuberculosis Testing Market was recently published by SDKI, which includes the latest market trends, current and future opportunities along with the factors that are driving the growth ...
- A mission to conquer tuberculosis and sleeping sickness in developing nationson February 25, 2021 at 4:45 am
That enables the bacteria to develop drug resistance." There is no gene exchange between bacterial cells in Mycobacterium tuberculosis (MTB), so MTB obtains drug resistance when a point mutation ...
- Investigation Finds Tuberculosis May Be Risk Factor for Behçet Diseaseon February 23, 2021 at 8:15 am
An analysis of human genetic and biomarker data found that tuberculosis was a risk factor for Behçet disease, a noninfectious uveitis condition.
- Aim to Eliminate Tuberculosis From Country By 2025, Says PM Modion February 22, 2021 at 11:20 pm
We aim to eliminate tuberculosis from the country by 2025. Wearing masks, early diagnosis and treatment are also important in its prevention, PM Modi said.
- A lemur died from tuberculosis. Here’s why that matters.on February 22, 2021 at 2:19 pm
The ring-tailed lemur was emaciated and suffering from advanced tuberculosis by the time she was turned over to the rescue facility in southwestern Madagascar in April 2019. An alarming, golf ...
- Study could explain tuberculosis bacteria paradoxon February 22, 2021 at 9:56 am
Tuberculosis bacteria have evolved to remember stressful encounters and react quickly to future stress, according to a study by computational bioengineers at Rice University and infectious disease ...
- Lysosome repositioning as an autophagy escape mechanism by Mycobacterium tuberculosis Beijing strainon February 22, 2021 at 8:09 am
Induction of host cell autophagy by starvation was shown to enhance lysosomal delivery to mycobacterial phagosomes, resulting in the restriction of Mycobacterium tuberculosis reference strain H37Rv.
- New biomarker predicts individual anti-tuberculosis treatment durationon February 20, 2021 at 10:51 am
When can tuberculosis therapy be stopped without risk of relapse? Doctors are faced with this question time and again, because the lack of detection of the tuberculosis pathogen Mycobacterium ...
via Google News and Bing News